{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:44:24Z","timestamp":1793508264474,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871409"],"award-info":[{"award-number":["81871409"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017649","name":"Hong Kong Government","doi-asserted-by":"publisher","award":["RFS2223-1S02"],"award-info":[{"award-number":["RFS2223-1S02"]}],"id":[{"id":"10.13039\/501100017649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017649","name":"Hong Kong Government","doi-asserted-by":"publisher","award":["PDFS2122-1S01"],"award-info":[{"award-number":["PDFS2122-1S01"]}],"id":[{"id":"10.13039\/501100017649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017649","name":"Hong Kong Government","doi-asserted-by":"publisher","award":["11200422"],"award-info":[{"award-number":["11200422"]}],"id":[{"id":"10.13039\/501100017649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017649","name":"Hong Kong Government","doi-asserted-by":"publisher","award":["11102218"],"award-info":[{"award-number":["11102218"]}],"id":[{"id":"10.13039\/501100017649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007567","name":"City University of Hong Kong","doi-asserted-by":"publisher","award":["7005433"],"award-info":[{"award-number":["7005433"]}],"id":[{"id":"10.13039\/100007567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007567","name":"City University of Hong Kong","doi-asserted-by":"publisher","award":["7005626"],"award-info":[{"award-number":["7005626"]}],"id":[{"id":"10.13039\/100007567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007567","name":"City University of Hong Kong","doi-asserted-by":"publisher","award":["7005210"],"award-info":[{"award-number":["7005210"]}],"id":[{"id":"10.13039\/100007567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007567","name":"City University of Hong Kong","doi-asserted-by":"publisher","award":["9667198"],"award-info":[{"award-number":["9667198"]}],"id":[{"id":"10.13039\/100007567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jconrel.2023.01.011","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T13:29:05Z","timestamp":1673357345000},"page":"208-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Multiple CEST contrast imaging of nose-to-brain drug delivery using iohexol liposomes at 3T MRI"],"prefix":"10.1016","volume":"354","author":[{"given":"Lok Hin","family":"Law","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.C.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongqi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.Y.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hei","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannie W.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.01.011_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","article-title":"Recent advances in drug delivery and targeting to the brain","volume":"350","author":"Sethi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","article-title":"Transport of drugs across the blood\u2013brain barrier by nanoparticles","volume":"161","author":"Wohlfart","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0020","first-page":"763","article-title":"Nanostructured lipid carriers for nose to brain delivery targeting CNS: diversified role of liquid lipids for synergistic action","volume":"12","author":"Tekade","year":"2021","journal-title":"Advanced, Pharmac. Bull."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0025","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/jps.2600741022","article-title":"Comparison of meclizine levels in the plasma of rats and dogs after intranasal, intravenous, and oral administration","volume":"74","author":"Chovan","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10611860802382777","article-title":"Delivery of testosterone to the brain by intranasal administration: comparison to intravenous testosterone","volume":"17","author":"Banks","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/jpet.108.149807","article-title":"Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke","volume":"330","author":"Hanson","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0040","first-page":"1","article-title":"CNS delivery of nucleic acid therapeutics: beyond the blood\u2013brain barrier and towards specific cellular targeting","author":"D\u2019Souza","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00415-018-9124-0","article-title":"Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients","volume":"266","author":"Wurster","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0050","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cpt.2531","article-title":"Translational approaches for brain delivery of biologics via cerebrospinal fluid","volume":"111","author":"Sadekar","year":"2022","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0055","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nano.2014.09.019","article-title":"Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI)","volume":"11","author":"Yu","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0075","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0080","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0085","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.molmed.2020.12.001","article-title":"Avoiding a sticky situation: bypassing the mucus barrier for improved local drug delivery","volume":"27","author":"Zierden","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0095","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2016.182","article-title":"The mucus barrier to inhaled gene therapy","volume":"24","author":"Duncan","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0100","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00419-2019","article-title":"Excess mucus viscosity and airway dehydration impact COPD airway clearance","volume":"55","author":"Lin","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.02.005","article-title":"A diaCEST MRI approach for monitoring liposomal accumulation in tumors","volume":"180","author":"Chan","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/17425247.2018.1429401","article-title":"Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery","volume":"15","author":"Battaglia","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114485","article-title":"Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders","volume":"189","author":"Correia","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0120","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/adhm.201300519","article-title":"Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth","volume":"3","author":"Yang","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0130","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/pharmaceutics12121230","article-title":"Intranasal nanoemulsions for direct nose-to-brain delivery of actives for cns disorders","volume":"12","author":"Bahadur","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/mrm.22761","article-title":"Chemical exchange saturation transfer (CEST): what is in a name and what isn\u2019t?","volume":"65","author":"Van Zijl","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/jmre.1999.1956","article-title":"A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)","volume":"143","author":"Ward","year":"2000","journal-title":"J. Magn. Reson."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0145","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nm907","article-title":"Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI","volume":"9","author":"Zhou","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0150","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/mrm.10651","article-title":"Amide proton transfer (APT) contrast for imaging of brain tumors","volume":"50","author":"Zhou","year":"2003","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0155","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/mrm.29044","article-title":"Deep neural network based CEST and AREX processing: application in imaging a model of Alzheimer\u2019s disease at 3 T","volume":"87","author":"Huang","year":"2022","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0160","doi-asserted-by":"crossref","first-page":"eaba3884","DOI":"10.1126\/sciadv.aba3884","article-title":"Altered d-glucose in brain parenchyma and cerebrospinal fluid of early Alzheimer\u2019s disease detected by dynamic glucose-enhanced MRI","volume":"6","author":"Huang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0165","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/mrm.24520","article-title":"Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer","volume":"68","author":"Chan","year":"2012","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0170","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm.3252","article-title":"In vivo imaging of glucose uptake and metabolism in tumors","volume":"19","author":"Walker-Samuel","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/nbm.3216","article-title":"CEST signal at 2 ppm (CEST@ 2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor","volume":"28","author":"Cai","year":"2015","journal-title":"NMR Biomed."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0180","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nm.2615","article-title":"Magnetic resonance imaging of glutamate","volume":"18","author":"Cai","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0185","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.neuroimage.2013.03.072","article-title":"Imaging of glutamate in the spinal cord using GluCEST","volume":"77","author":"Kogan","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0190","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1177\/0271678X20941264","article-title":"D-glucose uptake and clearance in the tauopathy Alzheimer\u2019s disease mouse brain detected by on-resonance variable delay multiple pulse MRI","volume":"41","author":"Chen","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0195","doi-asserted-by":"crossref","first-page":"e4640","DOI":"10.1002\/nbm.4640","article-title":"Sensitivity schemes for dynamic glucose-enhanced magnetic resonance imaging to detect glucose uptake and clearance in mouse brain at 3 T","volume":"35","author":"Huang","year":"2022","journal-title":"NMR Biomed"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mrm.20989","article-title":"Amide proton transfer imaging of human brain tumors at 3T","volume":"56","author":"Jones","year":"2006","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0205","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/mrm.21712","article-title":"Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging","volume":"60","author":"Zhou","year":"2008","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0210","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mrm.27751","article-title":"Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T","volume":"82","author":"Goerke","year":"2019","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0215","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mrm.20441","article-title":"Iopamidol: exploring the potential use of a well-established x-ray contrast agent for MRI, magnetic resonance in medicine: an official journal of the international society for","volume":"53","author":"Aime","year":"2005","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0220","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/mrm.21653","article-title":"Imaging pH using the chemical exchange saturation transfer (CEST) MRI: correction of concomitant RF irradiation effects to quantify CEST MRI for chemical exchange rate and pH","volume":"60","author":"Sun","year":"2008","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0225","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/mrm.25053","article-title":"Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI","volume":"72","author":"Chen","year":"2014","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0230","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/cmmi.1647","article-title":"A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH","volume":"10","author":"Moon","year":"2015","journal-title":"Contrast Med. Mol. Imag."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0235","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1007\/s00330-016-4552-7","article-title":"MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent","volume":"27","author":"Anemone","year":"2017","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0240","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cmmi.369","article-title":"Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents","volume":"5","author":"Terreno","year":"2010","journal-title":"Contrast Med. Mol. Imag."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0245","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.21037\/qims.2019.06.10","article-title":"CT and CEST MRI bimodal imaging of the intratumoral distribution of iodinated liposomes","volume":"9","author":"Chen","year":"2019","journal-title":"Quant. Imag. Med. Surg."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0250","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/mrm.23100","article-title":"In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes","volume":"67","author":"Liu","year":"2012","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0255","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.7150\/thno.40146","article-title":"CEST MRI detectable liposomal hydrogels for multiparametric monitoring in the brain at 3T","volume":"10","author":"Han","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0260","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1021\/acsabm.1c00411","article-title":"Imaging self-healing hydrogels and chemotherapeutics using CEST MRI at 3 T","volume":"4","author":"Han","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0265","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroimage.2013.03.047","article-title":"Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7 T","volume":"77","author":"Jones","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0270","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/mrm.24850","article-title":"Variable delay multi-pulse train for fast chemical exchange saturation transfer and relayed-nuclear overhauser enhancement MRI","volume":"71","author":"Xu","year":"2014","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0275","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.mri.2016.05.002","article-title":"A new NOE-mediated MT signal at around \u22121.6ppm for detecting ischemic stroke in rat brain","volume":"34","author":"Zhang","year":"2016","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0280","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mrm.28433","article-title":"Relayed nuclear Overhauser enhancement imaging with magnetization transfer contrast suppression at 3 T","volume":"85","author":"Huang","year":"2021","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0285","doi-asserted-by":"crossref","first-page":"102867","DOI":"10.1016\/j.nicl.2021.102867","article-title":"Relayed nuclear Overhauser effect weighted (rNOEw) imaging identifies multiple sclerosis","volume":"32","author":"Huang","year":"2021","journal-title":"NeuroImage: Clin."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0290","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/mrm.29241","article-title":"Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: application to brain tumors","volume":"88","author":"Zhou","year":"2022","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0295","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0300","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","article-title":"Influence of cholesterol on liposome stability and on in vitro drug release","volume":"5","author":"Briuglia","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0305","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1021\/acs.langmuir.2c00430","article-title":"Computational insights into the role of cholesterol in inverted hexagonal phase stabilization and endosomal drug release","volume":"38","author":"Ramezanpour","year":"2022","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0310","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1021\/ja710159q","article-title":"Size-induced enhancement of chemical exchange saturation transfer (CEST) contrast in liposomes","volume":"130","author":"Zhao","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0315","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1016\/j.chempr.2019.08.021","article-title":"Phorbiplatin, a highly potent Pt (IV) antitumor prodrug that can be controllably activated by red light","volume":"5","author":"Wang","year":"2019","journal-title":"Chem"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0320","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1016\/j.biomaterials.2007.05.044","article-title":"Targeted binding of PLA microparticles with lipid-PEG-tethered ligands","volume":"28","author":"Duncanson","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0325","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.gt.3302843","article-title":"Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid","volume":"14","author":"Hatakeyama","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0330","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","volume":"34","author":"Schuster","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, Physico-chemical characteristics and Mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"Ganger","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0340","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s13346-020-00816-2","article-title":"Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating","volume":"10","author":"de Oliveira Junior","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0345","first-page":"e4440","article-title":"Intranasal administration of CNS therapeutics to awake mice","volume":"74","author":"Hanson","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0350","doi-asserted-by":"crossref","first-page":"R221","DOI":"10.1088\/0031-9155\/58\/22\/R221","article-title":"Chemical exchange saturation transfer (CEST) and MR Z-spectroscopy in vivo: a review of theoretical approaches and methods","volume":"58","author":"Zaiss","year":"2013","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0355","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/mrm.23141","article-title":"In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T","volume":"67","author":"Jones","year":"2012","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0360","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jmr.2011.05.001","article-title":"Quantitative separation of CEST effect from magnetization transfer and spillover effects by Lorentzian-line-fit analysis of z-spectra","volume":"211","author":"Zai\u00df","year":"2011","journal-title":"J. Magn. Reson."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0365","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3716","article-title":"Accuracy in the quantification of chemical exchange saturation transfer (CEST) and relayed nuclear Overhauser enhancement (rNOE) saturation transfer effects","volume":"30","author":"Zhang","year":"2017","journal-title":"NMR Biomed."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0370","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/pharmaceutics14020451","article-title":"Molecular imaging of brain tumors and drug delivery using CEST MRI: promises and challenges","volume":"14","author":"Huang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0375","article-title":"Optimization of RPMI 2650 cells as a model for nasal mucosa","volume":"2014","author":"Pozzoli","year":"2014","journal-title":"Respirat. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.09.086","article-title":"Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs","volume":"515","author":"Gon\u00e7alves","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0385","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11095-014-1494-0","article-title":"The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model","volume":"32","author":"Kreft","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11100540","article-title":"Liposomal formulations for nose-to-brain delivery: recent advances and future perspectives","volume":"11","author":"Hong","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0395","doi-asserted-by":"crossref","first-page":"54401","DOI":"10.1021\/acsami.2c10493","article-title":"Monitor tumor pHe and response longitudinally during treatment using CEST MRI-detectable alginate microbeads","volume":"14","author":"Xiao","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.07.001","article-title":"PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy","volume":"285","author":"Osman","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0405","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1016\/j.biomaterials.2011.05.008","article-title":"Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus","volume":"32","author":"Lai","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0410","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s11064-021-03488-7","article-title":"Lipid-based Nanocarriers via nose-to-brain pathway for central nervous system disorders","volume":"47","author":"Nguyen","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0415","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2023.01.011_bb0420","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/pharmaceutics11110598","article-title":"Perivascular and perineural pathways involved in brain delivery and distribution of drugs after intranasal administration","volume":"11","author":"Lochhead","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.01.011_bb0425","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592300007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592300007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:42:28Z","timestamp":1777509748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592300007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":85,"alternative-id":["S016836592300007X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple CEST contrast imaging of nose-to-brain drug delivery using iohexol liposomes at 3T MRI","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}